Naloxone inhibits intermale aggression in isolated mice

The influence of the OPRM1 (A118G) polymorphism on behavioral and neural correlates of aggression in healthy males

Current models of aggression suggest that in addition to personality traits and environmental factors, biological vulnerability associated with genetics substantially impacts aggressive behavior. In a functional imaging study, we investigated the influence of the single nucleotide polymorphism of the mu 1 subtype opioid receptor gene (OPRM1), implicated in sociability, on correlates of trait and state aggression to delineate the function of these influences in aggression. A key aim was further to differentiate different aspects of aggressive reactions - namely, the reaction to provocation and the decision to punish an opponent. 59 healthy males performed a modified Taylor Aggression Paradigm during functional magnetic resonance imaging. The implementation of the paradigm allowed for individual assessments of the decision to behave aggressively, the experience of provocation and the ramification of punishment for the participant or the opponent. The influence of variation in the OPRM1 gene was measured by the functional A118G polymorphism. G allele carriers showed lower levels of general aggression and self-reported physical aggression. Additionally, these participants exhibited increased activation in dorsolateral prefrontal, orbitofrontal, anterior cingulate and insular cortices when choosing higher punishments for the opponent. The OPRM1 polymorphism did not influence aggression in reaction to social provocation. Thus, we suggest that this genetic variant affects one's trait aggressiveness rather than actual behavioral reactivity to provocation. Investigating brain regions that are specifically linked to provocation yielded activation in cortico-limbic circuits which might mediate the evaluation of provocation and the experience of anger and thus shed light on neural processes underlying the risk for aggressive behavior. This article is part of the Special Issue entitled 'Current status of the neurobiology of aggression and impulsivity'.

Decrease of kappa-opioid receptor mRNA level in ventral tegmental area of male mice after repeated experience of aggression

Brain opioid systems have been implicated in the regulation of social interaction, including agonistic behaviour. kappa-Opioid receptor B and C mRNA levels were decreased in the ventral tegmental area but not in the nucleus accumbens in male mice with repeated experience of social victories (winners), but not in mice after social defeats (losers) after 10 but not 20 days of confrontations. mu-Opioid receptor mRNA levels were not changed.

Effects of opiate ligands on intraspecific aggression in crickets

In the cricket Gryllus bimaculatus, the opiate antagonist naloxone, 30 microg in 50 microl into hemolymph per animal, caused a release of intraspecific aggression in male-losers and in females. Naloxone had no significant effect on the aggression of winners and isolated males. The agonist of mu-opiate receptors DAGO, 45 microg, suppressed aggression in male winners and decreased the percentage and duration of contact fights between previously isolated males. The results suggest that, during social contacts, the activity of the endogenous opioid system may contribute to suppressing aggression in subordinate males, as well as in females.

Effects of haloperidol on communicative and aggressive behavior in male mice with different experiences of aggression

Effects of two doses of haloperidol (0.1 and 0.4 mg/kg, 30 min and 24 h, IP) on communicative and aggressive behavior in C57BL/6J male mice have been studied. Some of the mice were without prior experience of aggression ("recruits"); the others had been victorious in 20 daily aggressive confrontations ("experienced winners"). Communicative behavior was estimated as the behavioral reaction to a standard tester (loser) in the partition test. Haloperidol in either dose significantly reduced communicative behavior in the "recruits." but not in the "experienced winners." Significantly fewer attacks, less total attacking time, and total time of aggressive behavior (aggressive grooming + attacks) were demonstrated by the "experiences winners," than by the "recruits," while the latency of the first attack, the number, the total and average duration of aggressive grooming events were significantly higher. In the "recruits," haloperidol dose dependently increased the latency and decreased the number of attacks, the total attacking time, and the total time of aggressive behavior 30 min and 24 h after injection. However, haloperidol did not affect the average or total time of aggressive grooming. Neither dose significantly affected any measure of aggressive behavior in the "experienced winners." It has been concluded that repeated aggression experience reduces the pharmacological sensitivity of the dopamine receptors.

Naloxone alters the local metabolic rate for glucose in discrete brain regions associated with opiate withdrawal

The current 2-deoxy-D-[1-14C]glucose investigation was performed to test the hypothesis that endogenous opioids influence basal synaptic activity within discrete brain regions. To examine this hypothesis, the effects of naloxone (1.0 mg/kg s.c.) on local cerebral metabolic rate for glucose (LCMRglu) in 84 brain regions were compared to saline controls. The specificity of naloxone's effects for opioid receptors was assessed by the coadministration of the opiate agonist morphine in a separate group. In naloxone-treated rats, there was a significant decrease in LCMRglu in the locus coeruleus (LC) and an increase in the central nucleus of the amygdala (CAMY), supporting a tonic influence of endogenous opioids on these regions. These metabolic changes were reversed by coadministered morphine, indicating that naloxone's metabolic actions are specific for opioid receptors. Based on the role of the LC and CAMY in opiate withdrawal, the present results suggest a subthreshold naloxone precipitated withdrawal from endogenous opioids. Although morphine administered alone significantly reduced LCMRglu in 16 brain regions, these did not include the LC or the CAMY. These results identify brain regions in which synaptic activity is under tonic modulation by endogenous opioids.

Effects of chlordiazepoxide on maternal aggression in mice depend on experience of resident and sex of intruder

Lactating mice respond differentially to intruders of differing sex, displaying defensive attack against the male and offensive attack against the female. Such a phenotypic dichotomy appears to have adaptive value in that unfamiliar males pose a much greater threat to the offspring than do females. The present study examined the effects of the benzodiazepine anxiolytic chlordiazepoxide (CDP) (2.5-10.0 mg/kg) on this differential response pattern in aggression-naive (nonscreened) (NS) and aggression-experienced (screened) (S) lactating female mice (Mus musculus domesticus) confronting intruders of either sex in a 10-min test. This procedure was used to evaluate the influence of both the type of opponent and previous aggressive experience on basal behavioural profiles and drug action. Results showed that both intruder sex and prior screening for attack modulated the behaviour of lactating females toward intruders. In turn, both variables strongly influenced CDP effects on maternal aggression. In particular, in S dams, CDP dose-dependently increased maternal attack against males but decreased attack against female intruders. Conversely, in NS dams, CDP decreased attack (and fear) against males but did not affect it against females. In both S and NS conditions, CDP modified the attack strategy of lactating females against the male, switching it from a defensive to an offensive pattern. Exploration, social investigation, eating, and immobility were differentially affected by the drug treatment, depending on screening and/or intruder sex condition. These differential effects of CDP between S and NS conditions, toward either male or female intruders, cannot be fully explained by differences in the baseline levels of these behaviours. Alternative hypotheses are discussed. These findings demonstrate that the effects of CDP on maternal attack behaviour depend on not only the drug but also the object of attack, and hence the function of attack and the prior experience of the attacker.

Effects of naloxone on the subjective and psychomotor effects of nitrous oxide in humans

The effects of naloxone on the mood-altering and psychomotor-impairing effects of nitrous oxide were examined in two studies. Each of the double-blind, randomized trials tested effects of three doses of naloxone or saline placebo during inhalation of 30% nitrous oxide in oxygen or 100% oxygen placebo. Experiment 1 tested a range of naloxone doses used clinically to reverse opiate-induced respiratory depression (0, 0.01, 0.1 1.0 mg/70 kg) and Experiment 2 included a dose approximately 25 times higher than that needed to reverse opiate-induced respiratory depression (0, 1.0, 3.0, 10 mg/70 kg). Nitrous oxide increased subject-rated reports of "feel drug effect," "carefree," "drunk," "sedated," and "high", and decreased psychomotor performance in both experiments. Naloxone had no effects by itself in either experiment, and, for the most part, did not significantly interact with nitrous oxide-induced changes in mood or psychomotor performance. Naloxone, in doses of 10 mg or less, does not appear to affect the subjective and psychomotor effects of nitrous oxide.

The influence of stress on convulsive parameters in the mouse

Mice exposed to the stress of conspecific aggression for 10 min showed shorter latencies to convulsions induced by pentylenetetrazol but not by pilocarpine. This effect was short lived and was not influenced by pretreatment with naltrexone (5 mg/kg, SC). The onset of pilocarpine-induced convulsions in stressed mice was reduced by the opioid antagonist. Aggression stress did not change the incidence, duration or severity of convulsions triggered by the chemoconvulsants or electroshock. The results differ widely from those obtained using other stressogenic models such as cold-restraint or swim stress. This suggests that alterations of convulsive parameters and the involvement of opioid mechanisms in their mediation are critically dependent on the characteristics of the stressogenic procedure employed.

The psychopharmacologic and prolactin response after large doses of naloxone in man

Large doses of naloxone (150-300 mg), placebo, and morphine (15-30 mg) were given intramuscularly to human volunteers and compared using measures of subjective feeling states, physiological measures and discriminative features. Plasma prolactin responses after naloxone 210 mg and placebo were compared. The subjective measures and discriminative features of naloxone revealed that the drug is subtly psychoactive but the stimulus is vague and cannot be identified clearly as an opioid agonist or antagonist in nondependent opioid-using volunteers. The physiologic and prolactin responses closely resembled opiate agonist activity. We conclude that naloxone in this dose range may act as an opiate agonist in man.

Naltrexone blocks amphetamine-induced hyperactivity, but not disruption of social and agonistic behavior in mice and squirrel monkeys

Significant anatomical overlap of opioid and dopamine receptors as well as reciprocity of control over synthesis, metabolism, and release of opioid peptides and dopamine in brain suggests functional interactions between the two systems. In the first of two studies, the behavioral effects of amphetamine and naltrexone alone, and in combination were studied in established groups of socially interacting squirrel monkeys. Naltrexone (0.1-10.0 mg/kg, IM) increased locomotion and marking behavior in subordinate monkeys. The frequency of social initiatives directed at treated subordinate monkeys by untreated members of the group was also increased. The behavior of dominant monkeys was relatively unaffected, except at the highest dose when autonomic distress was also evident. The frequency of walking bouts by both dominant and subordinate monkeys was increased by amphetamine (0.1-0.6 mg/kg, IM), and the social behavior of dominant monkeys was disrupted by drug treatment. Naltrexone (0.1 mg/kg, IM) significantly antagonized amphetamine's effects on motor behavior, and enhanced or did not affect amphetamine's effects on social behavior. In a second study, the interaction of amphetamine (0.63-10.0 mg/kg, IP) and naltrexone (0.1-10.0 mg/kg, IP) on the behavior of resident male mice during confrontations with a male intruder was studied. Naltrexone selectively reduced the frequency of attack at the highest dose tested. Amphetamine increased locomotor activity and decreased attack and threat behavior in resident mice. A low dose of naltrexone (1.0 mg/kg, IP) blocked amphetamine's effects on locomotion and enhanced the disruption of aggressive behavior. The amphetamine-naltrexone interaction on locomotor activity in mice and monkeys is consistent with opioid receptor modulation of dopamine mediated functions.(ABSTRACT TRUNCATED AT 250 WORDS)

Prolyl-leucyl-glycinamide (PLG): inhibition of offensive aggression in mice

The effects on offensive aggression of the endogenous peptide-leucyl-glycinamide (PLG, MIF-1) and the exogenous opiate antagonist, naloxone, were examined in male mice. PLG (0.01-10 mg/Kg) reduced, in a dose-dependent manner, the incidence and intensity of offensive aggression in dominant resident mice. PLG was more potent than naloxone (1.0 mg/Kg). In a number of cases, PLG completely eliminated the display of offensive aggression towards intruder mice. These results raise the possibility that PLG may function as an "anti-aggressive" peptide whose actions may include antagonistic and/or modulatory influences on both opioid and non-opioid systems.

Effects of naloxone upon the behavioural organisation of specific defeat activities in intruder mice: assessment by cluster analysis

The present experiment examined the effects of naloxone (0.5, 2.5 and 12.5 mg/kg) upon the responses of male Swiss mice to attack by aggressive male conspecifics in the resident-intruder paradigm by measuring the time spent in broad behavioural categories, frequency of individual acts or postures, and performing a cluster analysis of activities according to their frequency and position within the behavioural sequence. The former two measures detected little naloxone-induced change in behaviour. Cluster analysis revealed changes in behavioural organisation which suggested modification in the motivation and/or function underlying specific defeat behaviour.

Aggression during morphine withdrawal: effects of method of withdrawal, fighting experience, and social role

Offensive and defensive components of aggressive behavior were determined in resident and intruder mice. Withdrawal aggression was measured after the removal of a subcutaneous morphine pellet or after precipitation by naloxone in naive mice and after removal of a morphine pellet in mice with prior fighting experience. In naive mice, removal of a morphine pellet led to increases in attack bites and threats but naloxone-precipitated withdrawal led to decreases in these behaviors and to increases in defensive posturing, escape attempts and vocalizations. Prior fighting experience abolished the enhanced attack behaviors of resident mice following morphine pellet removal, but led to heightened defensive behavior in intruder mice. The behavior of intruder mice appeared more sensitive to naloxone administration than the behavior of resident mice; naloxone influenced not only intruder defensive behavior, but also other non-aggressive behaviors. The social role of the drug recipient and his prior history of aggressive behavior are important determinants of morphine and naloxone effects on aggression.

Effects of naloxone administration on attack by castrated male mice on lactating intruders

The effect of the narcotic antagonist naloxone (a mu blocker at low doses) on the attack displayed by castrated male mice towards lactating intruders was investigated. Naloxone at doses of 1 mg and 2 mg/kg decreased attacks an effect which was also evident to a lesser extent at 0.75 mg/kg. These findings suggest a role for endogenous opiates in the expression of this form of aggression although one must warn that naloxone at some of the higher doses used here can influence kappa and delta receptors as well as gabaergic activity. The interrelationships between endogenous opioids, gabaergic neurotransmission and gonadal hormones in the regulation of this attack response are discussed.

Social behaviour in pairs of C57BL/6 mice of both sexes in the open field: effects of saline drinking and of naloxone

We have previously found that saline drinking increases fighting in male pairs and decided to test this treatment (0.9% NaCl for 24 hours before test day 1; SAL) on social behaviour of both males and females. Paired C57BL/6 mice (same-sex pairs) were observed in the open field in daily sessions for three days. One member of each pair (test mouse) was given either SAL treatment, a control injection of saline (SI), an injection of naloxone (1 mg/kg IP; NLX) or a combination of both treatments (NLX + SAL). NLX alone had previously been found to increase aggression in resident/intruder tests at the dose used. Open field testing is not associated with aggressive encounters in our experience. SAL had little effect on (unaggressive) social behaviour in males, but increased social contact seeking in females. The NLX and NLX + SAL treatments had essentially the same effects, irrespective of sex; the treated animals showed behavioural inhibition (reduced social and ambulatory behaviour), while their untreated partners showed significantly more than normal interest in the naloxone treated mice. The results are discussed in terms of opioid involvement in social behaviour.

An ethological analysis of the effects of tifluadom on social encounters in male albino mice

The effects of treatment with saline, 0.5 or 1.0 mg/kg of tifluadom were assessed 30 min after injection on the behaviors shown by isolated Alderly Park strain mice in their home cages in the presence of an anosmic 'standard opponent' mouse. Tests involved videotaping encounters and examining the incidences of 45 behavioral elements and their sequences (by producing 'dendrograms'). The kappa agonist appeared to stimulate olfactory exploration of the substrate at the expense of other forms of non-social exploration; it suppressed olfactory investigation of the 'standard opponent'; reduced some aggressive elements and increased immobility (at reportedly non-sedative doses) and fearful activity. The 'dendrograms' revealed that tifluadom greatly altered the relationships between some elements. The higher dose of the kappa agonist resulted in self-grooming and digging (displacement?) being associated with the agonistic items suggesting that these animals evidenced increased timidity in social encounters.

Comparisons of the influence of morphine sulphate, morphine-3-glucuronide and tifluadom on social encounters in mice

The influences of morphine sulphate, morphine-3-glucuronide and tifluadom on social encounters were compared in male and female mice that were allowed to interact with an anosmic male partner. The drugs were compared, as morphine sulphate is thought to act via mu, and tifluadom via kappa opiate receptors; morphine-3-glucuronide is the breakdown product of morphine. Neither morphine sulphate nor morphine-3-glucuronide significantly influenced inter-male social encounters. However, tifluadom increased non-social and decreased social behaviour, while increasing timid/defensive activities. Tifluadom did not significantly influence the behaviour of female mice in this social encounter: in contrast both morphine sulphate and morphine-3-glucuronide decreased timid/defensive behaviour and stimulated non-social behaviour. It was concluded that the results could be explained by suggesting that morphine sulphate decreases whereas tifluadom increases timidity.

Mu and kappa opiate receptor involvement in agonistic behaviour in mice

The influence of opioid drugs on agonistic behaviour is reviewed and an experiment is reported that examines the impact of U-50488 (a kappa agonist) and DAGO (a mu agonist) on the social encounters of male and female mice interacting with anosmic male partners. Although DAGO did not significantly influence inter-male social encounters, U-50488 decreased social investigation, increased timid/defensive behaviour and potently suppressed aggression. In contrast, U-50488 did not significantly influence the behaviour of timid female mice, whereas DAGO decreased social and timid/defensive behaviour. It was concluded that a kappa mechanism increases whereas a mu mechanism decreases submissive behaviour.

Stimulation of aggression in male mice by alpha-MSH and its relation to light phase and to saline intake effects

The resident/intruder test was used to examine the social approach and aggressive behaviour of male albino mice. Digging, self-grooming and rearing were also recorded, as was the post-test response to hot-plate exposure. The resident mice were given either a single acute injection of MSH (MSH); 0.9% NaCl to drink (for 48 h prior to testing; SAL); a combination of both treatments (MSH + SAL) or an injection of 0.9% physiological saline (control group; CON). Testing was carried out at the midpoints of the light and dark phases of the 12:12 light cycle. Data on plasma ion levels and hypothalamic cAMP levels were collected after the hot-plate test. MSH stimulated fighting both in the light and dark, and SAL in the light. MSH + SAL reversed the effects of the single treatments in that fighting declined below CON levels in both light and dark. Social contact and other behaviours were much less affected by treatments. Pain responding and plasma ion levels were not changed. Effects on cAMP were largely inconclusive, but intruders had significantly lower levels than the aggressive resident animals.

Prolyl-leucyl-glycinamide reduces aggression and blocks defeat-induced opioid analgesia in mice

The effects of Prolyl-leucyl-glycinamide (PLG, MIF-1) and the exogenous opiate antagonist naloxone, on aggressive interactions and defeat-induced analgesia were examined in male mice. Both substances reduced the number of bites required to obtain defeat in subordinate mice during aggressive encounters as well as blocking the subsequent defeat-induced analgesia. These results suggest that MIF-1 may function as an endogenous opioid antagonist and have an inhibitory influence on aggression.

Saline drinking and naloxone: Lightcycle dependent effects on social behaviour in male mice

Male mice (TO strain) were observed in the resident-intruder test and several behaviours monitored. Treatments were: isotonic saline drinking ad lib for 48 hours before testing (SAL), IP injections of 1 mg/kg naloxone 30 minutes before testing (NLX) or both treatments combined (NLX + SAL). The same sequence of tests were carried out both in the light and the dark phase of the 24-hour light cycle. The single treatments (SAL and NLX) both increased fighting (SAL, p less than 0.02) in the light phase. The combined treatment (NLX + SAL), which reduced behavioural activity overall, caused a marked increase in the proportion of behaviour time spent on aggression (p less than 0.002). These effects were either reversed (significant reductions in aggression with SAL and NLX, p less than 0.05) or cancelled (minor reduction, NLX + SAL) in the dark phase. Partner body sniffing showed a trend towards lower levels following treatments in the light, and higher levels in the dark. No other behaviour changed systematically with treatments. Plasma sodium levels were monitored: there was a trend of treatment group mean sodium levels changing in proportion to the aggressogenic effect of the treatment, but it was not confirmed by correlation tests on the plasma sodium and aggression levels of individuals. The data are discussed in terms of a possible interaction between opioid receptors and physiological sodium chloride loads.

Endogenous opiates: 1983

This paper is the sixth in an annual series of reviews of research involving the endogenous opiates, each installment being restricted to work published during the previous year. Although the early articles in the series attempted to be comprehensive and cover the complete range of research with the opiate peptides, in the last two years we have limited our coverage to non-analgesic and behavioral work due to the enormous number of articles published in the field. The specific areas discussed here include stress, tolerance and dependence, consummatory responses, other gastrointestinal functions, interactions with alcohol, mental illness, learning and memory, cardiovascular responses, respiratory effects, thermoregulation, neurological disorders, activity, and miscellaneous other topics. As in previous years, we have attempted to present a relatively complete review of the subjects covered only for the previous year and generally have not tried to evaluate their contributions relative to those of past years.

Dissociation of prey killing and prey eating by naloxone in the rat

Mouse killing rats matched for killing latency and prey eating were injected (IP) with 0.5, 2.0, or 5.0 mg/kg naloxone or 0.9% saline. Naloxone did not significantly inhibit prey killing or alter prey killing latency at any dose but did reduce prey eating by 50% at the two higher doses. The dissociation of prey killing and prey eating by naloxone is consistent with other evidence that these two behaviors are separate components of predation in rats.

Modulation of isolation-induced fighting by N- and C-terminal analogs of substance P: evidence for multiple recognition sites

Substance P (SP) significantly reduced fighting in mice made aggressive by prolonged isolation. The N-terminal heptapeptide fragment SP (1-7) also reduced fighting. The C-terminal fragment SP(4-11) was without activity, while the shorter C-terminal fragment analog less than E-SP(7-11) significantly increased isolation-induced fighting. The aggression-enhancing effect of less than E-SP(7-11) was antagonized by naloxone, which by itself had no significant effect. The aggression-reducing effect of SP(1-11) was significantly enhanced by naloxone, while the effect of SP(1-7) was unchanged. These results demonstrate that a behavioral effect of SP may be duplicated by an N-terminal fragment of the SP molecule, and that peptide fragments or analogs of the N- and C-terminal portions of the SP molecule can exert opposing effects on a specific behavior. These findings represent a structure/activity relationship that is strikingly different from any previously described for SP. The differing effects of naloxone on N- and C-terminal fragment analogs suggest that these two effects may be mediated by different mechanisms.